ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $92,660,000 | +90.0% | 2,000,000 | 0.0% | 3.20% | +51.9% |
| Q1 2019 | $48,760,000 | +55.4% | 2,000,000 | +4.0% | 2.11% | +40.7% |
| Q1 2018 | $31,378,000 | -55.3% | 1,922,655 | -65.3% | 1.50% | -67.1% |
| Q4 2017 | $70,207,000 | +4.3% | 5,543,029 | -5.3% | 4.55% | -12.9% |
| Q3 2017 | $67,342,000 | +89.5% | 5,853,029 | +25.2% | 5.22% | +16.4% |
| Q2 2017 | $35,535,000 | +4.0% | 4,675,376 | +0.7% | 4.49% | +2.7% |
| Q1 2017 | $34,183,000 | +2331.2% | 4,641,400 | +2800.9% | 4.37% | +1437.7% |
| Q4 2016 | $1,406,000 | – | 160,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |